Fosamax Femur Plaintiffs Urge Supreme Court To Deny Preemption Review
WASHINGTON, D.C. — Counsel for more than 500 Fosamax femur fracture plaintiffs on Oct. 25 urged the U.S. Supreme Court to deny certiorari to Merck Sharp & Dohme Corp., arguing that...To view the full article, register now.
Already a subscriber? Click here to view full article